EVALUATION OF THE EFFECT OF TOLVAPTAN ON OXIDATIVE STRESS IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)

被引：0
|
作者：
Rigato, Matteo [1 ]
Bertoldi, Giovanni [1 ]
Ravarotto, Verdiana [1 ]
Carraro, Gianni [1 ]
Calo, Lorenzo [1 ]
机构：
[1] Univ Padua, Dept Med, Nephrol Dialysis & Transplantat Unit, Padua, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2021年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MO022
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Commentary: Tolvaptan for Autosomal Dominant Polycystic Kidney Disease (ADPKD) - an update
    Gittus, Matt
    Haley, Helen
    Harris, Tess
    Borrows, Sarah
    Padmanabhan, Neal
    Gale, Danny
    Simms, Roslyn
    Williams, Terri
    Acquaye, Aaron
    Wong, Alisa
    Chan, Melanie
    Lee, Eduardo
    Ong, Albert C. M.
    BMC NEPHROLOGY, 2025, 26 (01)
  • [2] THE BURDEN OF TOLVAPTAN TREATMENT FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD)
    Muto, Satoru
    Kawano, Haruna
    Sugiura, Syou-ichiro
    Kitamura, Kousuke
    Kimura, Masaki
    Isotani, Shuji
    Ide, Hisamitsu
    Yamaguchi, Raizo
    Horie, Shigeo
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [3] EFFICACY OF TOLVAPTAN ON AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS IN LATE STAGE CKD
    Hattanda, Fumihiko
    Nishio, Saori
    Takeda, Sayo
    Atsumi, Tatsuya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [4] Single center experience with tolvaptan in nine patients with autosomal dominant polycystic kidney disease (ADPKD)
    Hess, Nina
    Pollock, Emily
    Scharer, Verena
    Kobel, Claudia
    Weber, Nina
    Ritter, Alexander
    Mueller, Thomas
    Wuthrich, Rudolf P.
    Lorenzen, Johan
    SWISS MEDICAL WEEKLY, 2017, 147 : 13S - 13S
  • [5] Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
    Torres, Vicente E.
    Chapman, Arlene B.
    Devuyst, Olivier
    Gansevoort, Ron T.
    Grantham, Jared J.
    Higashihara, Eiji
    Perrone, Ronald D.
    Krasa, Holly B.
    Ouyang, John
    Czerwiec, Frank S.
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25): : 2407 - 2418
  • [6] The Effect of Dietary Intervention on Autosomal-Dominant Polycystic Kidney Disease (ADPKD) Patients on Tolvaptan and Their Quality of Life
    Tarabzuni, Ola
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [7] The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease
    Kawada, Tomoyuki
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2016, 20 (01) : 147 - 148
  • [8] The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease
    Tomoyuki Kawada
    Clinical and Experimental Nephrology, 2016, 20 : 147 - 148
  • [9] Clinical Utility and Tolerability of Tolvaptan in the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    Raina, Rupesh
    Houry, Ahmad
    Rath, Pratik
    Mangat, Guneive
    Pandher, Davinder
    Islam, Muhammad
    Khattab, Ala'a Grace
    Kalout, Joseph K.
    Bagga, Sumedha
    DRUG HEALTHCARE AND PATIENT SAFETY, 2022, 14 : 147 - 159
  • [10] EFFICACY OF TOLVAPTAN ON AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS IN LATE-STAGE CKD
    Hattanda, Fumihiko
    Makita, Minoru
    Takeda, Sayo
    Watanabe, Kanako
    Kawashima, Keisuke
    Kondo, Keiichi
    Ishikawa, Yozou
    Kusunoki, Yoshihiro
    Ishikawa, Yasunobu
    Nishio, Saori
    Atsumi, Tatsuya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 106 - 106
12345